Evidence map›Paper›PMID 41422144›Full record

ArticleScientific reports2025

Missense variant in TTBK2 kinase domain causes loss of function and impaired protein phosphorylation.

Daniela Felício, Hugo Osório, Conceição Pereira, Ana Filipa Brandão, João Parente Freixo, Inês Carvalho, Ana Paula Sousa, Margarida Castro-Caldas, Jorge Sequeiros, Carolina Lemos and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daniela FelícioIBMC-Institute for Molecular and Cell Biology, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Hugo OsórioIpatimup-Institute of Molecular Pathology and Immunology, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Conceição PereiraIBMC-Institute for Molecular and Cell Biology, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Ana Filipa BrandãoCGPP-Centre for Predictive and Preventive Genetics, IBMC-Institute for Molecular and Cell Biology, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
João Parente FreixoCGPP-Centre for Predictive and Preventive Genetics, IBMC-Institute for Molecular and Cell Biology, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Inês CarvalhoHospital Dona Estefânia, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal.
Ana Paula SousaCentro Hospitalar Universitário de Santo António, ULS de Santo António, Porto, Portugal.
Margarida Castro-CaldasUCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal.
Jorge SequeirosIBMC-Institute for Molecular and Cell Biology, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Carolina LemosIBMC-Institute for Molecular and Cell Biology, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Mariana SantosIBMC-Institute for Molecular and Cell Biology, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. marianasmg@gmail.com.

Funding

Ataxia UK ZGRACAFundação para a Ciência e a Tecnologia DL 57/2016 - Norma TransitóriaFundação para a Ciência e a Tecnologia UI/BD/154402/2023Fundação para a Ciência e a Tecnologia UIDB/00215/2020, UIDP/00215/2020, LA/P/0064/2020 , UID/215/2025Rede Nacional de Espectrometria de Massa ROTEIRO/0028/2013; LISBOA-01-0145-FEDER-022125
6 · The paper itself

Abstract

Tau tubulin kinase 2 (TTBK2) is a ubiquitous serine-threonine protein kinase implicated in diverse cellular processes, including microtubule regulation, ciliogenesis, synaptic signaling, and the phosphorylation of key proteins like TDP-43. Despite its relevance, many aspects of TTBK2 function in both physiological and pathological conditions remain poorly understood. Truncating variants in TTBK2 gene cause spinocerebellar ataxia type 11 (SCA11), a rare form of autosomal dominant cerebellar ataxia. However, the functional consequences and pathogenic potential of missense variants have yet to be elucidated. In this study, we developed a CRISPR/Cas9 knock-in cell model harboring a missense variant in TTBK2 kinase domain (NM_173500.4:c.625 C > T; p.Leu209Phe) to evaluate its impact on TTBK2 expression, associated protein levels, and phosphoproteomic profiles. TTBK2 missense variant (TTBK2-L209F) was associated with reduced TTBK2 protein levels, altered levels of cytoskeleton-related proteins, and impaired kinase activity, namely toward TDP-43. Phosphoproteomic analyses identified dysregulation in pathways linked to gene regulation, protein degradation, cytoskeletal organization, and TGF-β signaling. These findings provide valuable insights into the biological roles of TTBK2 in cellular signaling. Moreover, this study underscores the importance of functional studies to better understand the consequences of TTBK2 missense variants, particularly those affecting the kinase domain, and their potential contribution to disease.

Indexed as

Loss of Function MutationMutation, MissenseProtein Serine-Threonine KinasesCRISPR-Cas SystemsHEK293 CellsHumansPhosphorylationProtein DomainsProtein Serine-Threonine Kinasestau-tubulin kinaseCRISPR/Cas9Cytoskeleton.Kinase activityPhosphoproteomicsSpinocerebellar ataxia type 11 (SCA11)Tau-tubulin kinase 2 (TTBK2)

Identifiers

PMID41422144
PMCPMC12820296

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.